Drugs / Nexrutine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01705652 | Jul 2011 → Mar 2014 | prostate cancer | The University of Texas Health Science Center at San Antonio | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nexrutine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01705652 ↗ |
| Route | Oral | “by mouth” NCT01705652 ↗ |